Hamartoma: Clinical Trials

141 trials for Hamartoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

67 completed, 28 recruiting, 13 unknown, 12 active not recruiting. 42 Phase 2, 21 Phase 1, 20 Phase 3, 19 Not applicable, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 242Completed 24, Active not recruiting 4, Unknown 4, Recruiting 3, Withdrawn 3, Not yet recruiting 2, Terminated 2
Phase 121Completed 15, Active not recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 320Completed 11, Recruiting 3, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Not applicable19Completed 6, Unknown 5, Recruiting 3, Enrolling by invitation 2, Withdrawn 2, Active not recruiting 1
Phase 46Completed 4, Active not recruiting 1, Terminated 1

Follow Hamartoma: new trials by email Literature Review of Hamartoma trials Research Report on Hamartoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurocutaneous Syndromes in Children: Prevalence and Clinical Characteristics
Sturge-Weber Syndrome, Neurocutaneous Syndromes
Not yet recruitingAssiut University1002026-09-202026-09-28
Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1)
AV078, Placebo - Tuberous Sclerosis Complex, Epilepsy
Phase 2Not yet recruitingAeovian Pharmaceuticals, Inc.422026-09-012026-09-29
Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations
Everolimus blinded oral capsules, Placebo - Cowden's Disease, Cowden's Syndrome
Phase 2 / Phase 3Not yet recruitingBoston Children's Hospital602026-09-012026-06-04
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
SVG103 - Focal Cortical Dysplasia, Tuberous Sclerosis Complex (TSC)
Phase 1 / Phase 2RecruitingSovargen122026-07-142026-08-10
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Observational assessment - Periodontal Disease, Periodontitis
RecruitingStefan Lujinschi1002026-05-042026-06-26
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
Use of an electronic digital Application - Chronic Kidney Disease, Proteinuria
Not applicableRecruitingSt. James's Hospital, Ireland802026-01-142026-05-01
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Sapu003, Exemestane 25 MG - Breast Cancer Metastatic, Renal Cell Carcinoma (RCC)
Phase 1RecruitingSAPU NANO (US) LLC272025-12-152026-01-27
TANDem-2: Closing the Gap to Interventions for TAND
Well-Beans for Caregivers Program - Adult Caregivers of Individuals With TSC, Tuberous Sclerosis Complex (TSC)
Not applicableEnrolling by invitationVrije Universiteit Brussel302025-07-152025-09-22
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
Radiprodil + co-administered drugs - Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia
Phase 1CompletedGRIN Therapeutics, Inc.182025-05-202025-11-18
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
Radiprodil with Carbamazepine, Radiprodil with Itraconazole - Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia
Phase 1TerminatedGRIN Therapeutics, Inc.302025-05-082025-11-21
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
Epidiolex 100 mg/mL Oral Solution - Lennox Gastaut Syndrome, Dravet Syndrome
Active not recruitingJazz Pharmaceuticals1112025-02-242026-06-03
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
Nipple Sparing Mastectomy (NSM), Skin-Sparing Mastectomy (SSM), Total (Simple) Mastectomy - Breast Cancer Surgery
RecruitingSir Mortimer B. Davis - Jewish General Hospital47002025-02-012026-08-18
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Sertraline, Placebo - Neurodevelopmental Disorders, Autism
Phase 2RecruitingHolland Bloorview Kids Rehabilitation Hospital1302024-09-162026-07-27
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach
Amygdalo-Hippocampectomy - Hippocampal Sclerosis, Dysembryoplastic Neuroepithelial Tumor
RecruitingUniversity Hospital, Montpellier35042024-08-312025-04-08
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
PTEN Hamartoma Syndrome
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta502024-08-012026-02-12
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
Radiprodil - Tuberous Sclerosis Complex, Focal Cortical Dysplasia
Phase 1 / Phase 2Active not recruitingGRIN Therapeutics, Inc.302024-07-102026-04-01
Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Sirolimus, Placebo - PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Phase 1 / Phase 2WithdrawnStanford University2024-07-012024-07-10
Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
YCJ-01 Full Spectrum cannbis Extract, Placebo - Tuberous Sclerosis Complex (TSC)
Phase 3RecruitingOils4Cure842024-06-012026-02-11
Video Capsule Examination in Patients With Lynch Syndrome
Video capsule investigation - Lynch Syndrome, Li Fraumeni Syndrome
Not applicableRecruitingRoyal Marsden NHS Foundation Trust252024-03-042024-12-05
Reproductive Options in Inherited Skin Diseases
Ichthyosis, Palmoplantar Keratoses
Enrolling by invitationMaastricht University Medical Center6502024-01-012025-05-18

Showing 20 of 141. Sign in to see all of them.

Narrower conditions

Tuberous Sclerosis (114)  ·  Epilepsy (22)  ·  Hamartoma Syndrome, Multiple (21)  ·  Lymphangioleiomyomatosis (16)  ·  Seizures (14)  ·  Autistic Disorder (13)  ·  Epilepsies, Myoclonic (8)  ·  Lennox Gastaut Syndrome (8)  ·  Angiomyolipoma (7)  ·  Focal Cortical Dysplasia (7)  ·  Hereditary Sensory and Autonomic Neuropathies (6)  ·  Li-Fraumeni Syndrome (6)  ·  Angiofibroma (5)  ·  Astrocytoma (5)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (5)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (139)  ·  Neoplasms (137)  ·  Neoplasms, Multiple Primary (137)  ·  Genetic Diseases, Inborn (133)  ·  Neoplastic Syndromes, Hereditary (131)  ·  Congenital Abnormalities (123)  ·  Nervous System Diseases (122)  ·  Nervous System Malformations (119)  ·  Malformations of Cortical Development, Group I (117)  ·  Heredodegenerative Disorders, Nervous System (116)  ·  Neurodegenerative Diseases (116)  ·  Malformations of Cortical Development (114)  ·  Neurocutaneous Syndromes (111)  ·  Neoplasms by Histologic Type (42)

Interventions

Everolimus (20)  ·  Sirolimus (18)  ·  Cannabidiol (6)  ·  Activator Appliances (3)  ·  Miransertib (3)  ·  Vigabatrin (3)  ·  ganaxolone (3)  ·  radiprodil (3)  ·  Melatonin (2)  ·  dactolisib (2)  ·  2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine (1)  ·  8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethylphenyl)-1,3-dihydroimidazo(4,5-c)quinolin-2-one (1)  ·  Acceptance and Commitment Therapy (1)  ·  Actigraphy (1)  ·  Anticonvulsants (1)

Sponsors

Novartis Pharmaceuticals (8)  ·  Children's Hospital Medical Center, Cincinnati (7)  ·  Jazz Pharmaceuticals (6)  ·  Boston Children's Hospital (5)  ·  National Heart, Lung, and Blood Institute (NHLBI) (5)  ·  National Human Genome Research Institute (NHGRI) (5)  ·  University of California, Los Angeles (5)  ·  Beijing Children's Hospital (3)  ·  GRIN Therapeutics, Inc. (3)  ·  Longboard Pharmaceuticals (3)  ·  Marinus Pharmaceuticals (3)  ·  Nobelpharma (3)  ·  Cardiff University (2)  ·  Dana-Farber Cancer Institute (2)  ·  Erasmus Medical Center (2)

Countries

United States (79)  ·  United Kingdom (20)  ·  Australia (18)  ·  Canada (15)  ·  Spain (15)  ·  France (14)  ·  Italy (13)  ·  Netherlands (13)  ·  Poland (11)  ·  China (9)  ·  Belgium (7)  ·  Germany (6)  ·  Japan (6)  ·  Israel (4)  ·  Turkey (Türkiye) (4)

Top investigators

Leslie G Biesecker, M.D. (4)  ·  Darcy Krueger, MD, PhD (3)  ·  Joel Moss, M.D. (3)  ·  Mustafa Sahin, MD, PhD (3)  ·  Anna Jansen, MD, PhD (2)  ·  Antoni Gostynski, MD, PhD (2)  ·  Antonio Hardan, MD (2)  ·  Dennis J Dlugos, MD (2)  ·  Hope Northrup, MD (2)  ·  John Bissler, MD (2)  ·  Martina Bebin, MD, MPA (2)  ·  Mary Kay Koenig, MD (2)  ·  Alessandra Pereira,, PhD, MD (1)  ·  Alessandro Flavio Ferri (1)

Results publications

PMID 29023494, PMID 30053159, PMID 30291925, PMID 31912454, PMID 34649967, PMID 34957550, PMID 38996393, PMID 18184959, PMID 19141364, PMID 20458532, PMID 21047224, PMID 21482669, PMID 21525172, PMID 21915260, PMID 22113127, PMID 22262746, PMID 22934754, PMID 23158522, PMID 23325902, PMID 23344409, PMID 23437092, PMID 23732715, PMID 23733802, PMID 23798472, PMID 24729041, PMID 25456370, PMID 25682485, PMID 26156073, PMID 26381530, PMID 26858193, PMID 27222591, PMID 27351628, PMID 29096777, PMID 29572283, PMID 29797247, PMID 29800026, PMID 29800048, PMID 30192751, PMID 30424962, PMID 30803705, PMID 31217257, PMID 31237569, PMID 31350329, PMID 31444548, PMID 31969108, PMID 31982581, PMID 32385845, PMID 33346789, PMID 33407896, PMID 33434304

NIH funding

U54NS092090 (3), 2015 (2), 2018 (2), 2023 (2), 2008 (1), 2025 (1), P30CA006516 (1), R01CA107164 (1), R01HD090138 (1), R21CA103486 (1), U01NS082320 (1), U01NS092595 (1)